Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Gastroentrology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Oncology
    • Opioids
    • Rare Diseases
  • RESOURCES
  • CONTACT

Myasthenia Gravis Research Highlights: AAN 2024

  • Post author By salmocc
  • Post date September 24, 2024

Myasthenia Gravis Research Highlights: AAN 2024

 Rare Diseases

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Listing ID: 2936

← Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings → Case Studies in ART and Retention in Care